Cargando…

Commentary: A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson's Disease

Detalles Bibliográficos
Autores principales:	Muñoz, Patricia, Segura-Aguilar, Juan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913531/ https://www.ncbi.nlm.nih.gov/pubmed/27378526 http://dx.doi.org/10.3389/fphar.2016.00179

Ejemplares similares

A Humanized Clinically Calibrated Quantitative Systems Pharmacology Model for Hypokinetic Motor Symptoms in Parkinson’s Disease
por: Roberts, Patrick, et al.
Publicado: (2016)

Quantitative Analysis of Relationship Between Hypokinetic Dysarthria and the Freezing of Gait in Parkinson’s Disease
por: Mekyska, Jiri, et al.
Publicado: (2018)

Hypokinetic Dysarthria in Parkinson’s Disease: A Narrative Review
por: Atalar, Merve Sapmaz, et al.
Publicado: (2023)

Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Arytenoid cartilage movements are hypokinetic in Parkinson’s disease: A quantitative dynamic computerised tomographic study
por: Perju-Dumbrava, Laura, et al.
Publicado: (2017)

Corrigendum: Commentary: Evaluation of Models of Parkinson's Disease
por: Muñoz, Patricia, et al.
Publicado: (2016)

Low physical activity is associated with two hypokinetic motor abnormalities in psychosis
por: Walther, Sebastian, et al.
Publicado: (2022)

Computerized analysis of hypomimia and hypokinetic dysarthria for improved diagnosis of Parkinson's disease
por: Skibińska, Justyna, et al.
Publicado: (2023)

Pedunculopontine Nucleus Degeneration Contributes to Both Motor and Non-Motor Symptoms of Parkinson’s Disease
por: Chambers, Nicole Elaine, et al.
Publicado: (2020)

Commentary: Pharmacological Interventions for Bacterial Prostatitis
por: Magri, Vittorio, et al.
Publicado: (2020)

Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study
por: Gu, Si-Chun, et al.
Publicado: (2022)

Hypokinetic Activity of Menthofuran on the Gastrointestinal Tract in Rodents
por: Santos, Railson de Sousa, et al.
Publicado: (2023)

Editorial: The emerging discipline of quantitative systems pharmacology
por: Leil, Tarek A., et al.
Publicado: (2015)

Brain morphological changes in hypokinetic dysarthria of Parkinson's disease and use of machine learning to predict severity
por: Chen, Yingchuan, et al.
Publicado: (2020)

A Neuromotor to Acoustical Jaw-Tongue Projection Model With Application in Parkinson’s Disease Hypokinetic Dysarthria
por: Gómez, Andrés, et al.
Publicado: (2021)

Hypokinetic hypertrophic cardiomyopathy: clinical phenotype, genetics, and prognosis
por: Wasserstrum, Yishay, et al.
Publicado: (2022)

A computer-based quantitative systems pharmacology model of negative symptoms in schizophrenia: exploring glycine modulation of excitation-inhibition balance
por: Spiros, Athan, et al.
Publicado: (2014)

Functional and cognitive capacity differ in dystonic motor subtypes when compared to choreatic and hypokinetic‐rigid motor subtypes in Huntington's disease
por: Achenbach, Jannis, et al.
Publicado: (2020)

Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson’s Disease
por: Murueta-Goyena, Ane, et al.
Publicado: (2019)

Commentary: Gene Therapy: A Promising Approach for Neuroprotection in Parkinson's Disease?
por: Segura-Aguilar, Juan
Publicado: (2017)

Chinese Herbal Products for Non-Motor Symptoms of Parkinson’s Disease in Taiwan: A Population-Based Study
por: Lin, Chien-Hung, et al.
Publicado: (2021)

Toward a greater understanding of the syndemic nature of hypokinetic diseases
por: Cardinal, Bradley J.
Publicado: (2016)

An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Gastric Antiulcerogenic and Hypokinetic Activities of Terminalia fagifolia Mart. & Zucc. (Combretaceae)
por: Nunes, Paulo Humberto M., et al.
Publicado: (2014)

Hypokinetic Biliary Dyskinesia in a Pediatric Patient: A Case Report
por: Klein, Sarah, et al.
Publicado: (2023)

Quantitative Systems Pharmacology can reduce attrition and improve productivity in pharmaceutical research and development
por: Leil, Tarek A., et al.
Publicado: (2014)

Multitarget Multiscale Simulation for Pharmacological Treatment of Dystonia in Motor Cortex
por: Neymotin, Samuel A., et al.
Publicado: (2016)

Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
por: Stayte, Sandy, et al.
Publicado: (2014)

Considerations for Adapting Pre-existing Mechanistic Quantitative Systems Pharmacology Models for New Research Contexts
por: Weis, Michael, et al.
Publicado: (2019)

Delayed onset hypokinetic-rigid syndrome due to hypoxic-ischemic damage of the striatum
por: Moudrous, Walid, et al.
Publicado: (2016)

Speckle tracking echocardiography in hypokinetic non‐dilated cardiomyopathy: comparison with dilated cardiomyopathy
por: Mombeini, Hoda, et al.
Publicado: (2020)

Treatment of unexplained coma and hypokinetic-rigid syndrome in a patient with COVID-19
por: Roy, Devjit, et al.
Publicado: (2021)

Commentary: Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach
por: Amar, Avishek
Publicado: (2017)

Editorial: Pharmacology of BPSD (Behavioral and Psychological Symptoms of Dementia)
por: Giménez-Llort, Lydia, et al.
Publicado: (2021)

Quantitative Systems Pharmacological Analysis of Drugs of Abuse Reveals the Pleiotropy of Their Targets and the Effector Role of mTORC1
por: Pei, Fen, et al.
Publicado: (2019)

Quantitative Systems Pharmacology Model-Based Predictions of Clinical Endpoints to Optimize Warfarin and Rivaroxaban Anti-Thrombosis Therapy
por: Hartmann, Sonja, et al.
Publicado: (2020)

A Quantitative Systems Pharmacology Model of Liver Lipid Metabolism for Investigation of Non-Alcoholic Fatty Liver Disease
por: Rieger, Theodore R., et al.
Publicado: (2022)

Pharmacological management of Parkinson’s disease motor symptoms: update and recommendations from an expert
por: Kulisevsky, Jaime
Publicado: (2022)

Sequence Complexity Effects on Speech Production in Healthy Speakers and Speakers with Hypokinetic or Ataxic Dysarthria
por: Reilly, Kevin J., et al.
Publicado: (2013)

Rhythmic performance in hypokinetic dysarthria: Relationship between reading, spontaneous speech and diadochokinetic tasks
por: Lowit, Anja, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_dem3p57c1aa8jqo6dtmia57fea